Cargando…
Risk Prediction and New Prophylaxis Strategies for Thromboembolism in Cancer
In the general population, the incidence of thromboembolic events is 117 cases/100,000 inhabitants/year, while in cancer patient incidence, it is four-fold higher, especially in patients who receive chemotherapy and who are affected by pancreatic, lung or gastric cancer. At the basis of venous throm...
Autores principales: | Labianca, Alice, Bosetti, Tommaso, Indini, Alice, Negrini, Giorgia, Labianca, Roberto Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7466093/ https://www.ncbi.nlm.nih.gov/pubmed/32726933 http://dx.doi.org/10.3390/cancers12082070 |
Ejemplares similares
-
Risk Prediction and New Prophylaxis Strategies for Thromboembolism in Cancer
por: Ferroni, Patrizia, et al.
Publicado: (2021) -
A New Risk Prediction Model for Venous Thromboembolism and Death in Ambulatory Lung Cancer Patients
por: Gomez-Rosas, Patricia, et al.
Publicado: (2023) -
Chemotherapy-associated thromboembolic risk in cancer outpatients and effect of nadroparin thromboprophylaxis: results of a retrospective analysis of the PROTECHT study
por: Barni, Sandro, et al.
Publicado: (2011) -
Optimizing use of opiates in the management of cancer pain
por: Mandalà, Mario, et al.
Publicado: (2006) -
Novel treatment strategies for early-stage lung cancer: the oncologist’s perspective
por: Indini, Alice, et al.
Publicado: (2020)